Potential Celiac Disease Vaccine Currently in Clinical Trials
ImmusanT, a biotech company working to develop treatment and a set of diagnostic tools to help manage patients with Celiac disease (CD) recently announced new research involving advancement towards a possible vaccine. The company’s treatment approach involves creating a vaccine that is based on the same principles used for traditional allergy therapy: reprogramming the immune…